Cargando…
KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer
Ovarian cancer (OV) is a gynaecological malignancy that poses a serious risk to the health status of women. To date, effective molecular markers are unavailable for the diagnosis and management of ovarian malignancies. In this study, we aimed to investigate the molecular markers associated with the...
Autores principales: | Wang, Xingwei, Sun, Ru, Hong, Xia, Chen, Chen, Ding, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423958/ https://www.ncbi.nlm.nih.gov/pubmed/36046368 http://dx.doi.org/10.1155/2022/9799346 |
Ejemplares similares
-
KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Wu, Qiulin, et al.
Publicado: (2020) -
Tissue- and Cell Type-Specific Expression of the Long Noncoding RNA Klhl14-AS in Mouse
por: Credendino, Sara Carmela, et al.
Publicado: (2017) -
A synthetic KLHL20 ligand to validate CUL3(KLHL20) as a potent E3 ligase for targeted protein degradation
por: Farrell, Brian M., et al.
Publicado: (2022) -
Clinical Outcome in KLHL24 Cardiomyopathy
por: Vermeer, Mathilde C.S.C., et al.
Publicado: (2023) -
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2021)